Bengaluru-based startup GenWorks Health has partnered with Medtronic to redefine how intrauterine abnormalities are treated.

The TruClear system by Medtronic offers a complete technology platform for the removal of a range of intrauterine abnormalities. Doctors in the West have now moved on to innovations like Mechanic Hysteroscopic Tissue Removal (MHTR) systems, in which pathology removal, including fibroids or polyps are being treated in the outpatient setting without any need for general anaesthesia or the use of any heat energy, a risky procedure which was previously used. MHTR also enables surgeons to see and treat at the same setting using a single insertion apart from removing as much as 98 percent of the diseased tissues.

Ganesh Prasad Founder, MD and CEO GenWorks Health said, "While the last 2 decades have brought great focus on adoption of technology to save lives, tech adoption for women’s wellness is almost non-existent. We serve the maximum women’s health specialists in our country and hence are able to put together solutions from early screening to safe treatment.’’

Prasad further said, "The addition of TruClear is a huge opportunity for safe treatment and almost freedom from archaic practices that affect the wellbeing of our women.’’